Literature DB >> 17357663

[Chlamydia pneumoniae occurrence in children with adenoid vegetations].

Maria Zalesska-Krecicka1, Irena Choroszy-Król, Aleksandra Skrzypek, Monika Morawska-Kochman, Dorota Teryks-Wołyniec, Magdalena Frej-Madrzak, Iwona Kaufeld-Budrewicz.   

Abstract

INTRODUCTION: In world literature there is a lack on informations about occurrence frequency of Chlamydia pneumoniae in swabs fromadenoid vegetations. Chlamydia spp. is a group of nontypical pathogenetic bacteria. Initially they were fought a cause of lower respiratory tract. Nowadays they are considered as a pathogenetic factor of upper respiratory tract infections. They can also cause persistant infection.
MATERIAL AND METHODS: During 3,5 months at the end of winter and bigining of spring, 110 children qualified to adenotomy (53 girls and 57 boys) were examinated. The average of age carried out 6,11 years.
RESULTS: the positive results of direct immunophluorescence test (IFA) of adenoid vegetations swabs were received in 29 children (26.4%). Received results demonstrate chronic infection with Chlamydia pneumoniae. Pneumonia or bronchitis was noted additionally at 3 children (2.7%) in this in one child pneumonia caused by C. pneumoniae was diagnosed, secretory otitis media was diagnosed in 5 children (4,5%), asthma in 3 patients (2,7%). Confirmed infection Chlamydia pneumoniae occurred earlier at 5 children (4.5%).
CONCLUSION: Results of direct immunophluorescence test(IFA) of adenoid vegetations swabs do not correlate directly with levels of anty-C. pneumoniae antybodies in blood. But antybody level could be supplementary to clinical symptoms and and swab result or give us information about infection history in patient.

Entities:  

Mesh:

Year:  2006        PMID: 17357663

Source DB:  PubMed          Journal:  Otolaryngol Pol        ISSN: 0030-6657


  1 in total

1.  Respiratory infection caused by Chlamydophila pneumoniae in children and adolescents in the Lower Silesia Region of Poland.

Authors:  Irena Choroszy-Krol; I M Frej-Madrzak; D Teryks-Wolyniec; A Jama-Kmiecik; G Gosciniak; I Pirogowicz; M Pokorski
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.